(Q83302191)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16681421%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Molecular detection of squamous cell carcinoma antigen transcripts in peripheral blood of cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16681421%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

main subject

squamous cell carcinoma

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16681421%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Hatice Tigli

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16681421%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Derya Duranyildiz

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16681421%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Nejat Dalay

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16681421%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16681421%20AND%20SRC:MED&resulttype=core&format=json

Clinical Chemistry and Laboratory Medicine

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16681421%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16681421%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16681421%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

538-541

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16681421%20AND%20SRC:MED&resulttype=core&format=json

Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

Squamous-cell carcinoma antigen (SCC-A) values related to clinical outcome of pre-invasive and invasive cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

Serine protease inhibitor activity of recombinant squamous cell carcinoma antigen towards chymotrypsin, as demonstrated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

The value of squamous cell carcinoma antigen as a predictor of nodal metastasis in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

Squamous cell carcinoma antigen is a new member of the serine protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

Correlation of squamous cell carcinoma antigen levels and treatment response in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

Squamous cell carcinoma antigen is a potent inhibitor of cysteine proteinase cathepsin L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

Diagnostic and prognostic significance of squamous cell carcinoma antigen in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial determinations and tissue localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

Clinical value of pretreatment serum Cyfra 21-1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

Clinical prediction rules. A review and suggested modifications of methodological standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

Lipid-associated sialic acid, squamous cell carcinoma antigen, carcinoembryonic antigen, and lactic dehydrogenase levels as tumor markers in squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

Availability of tumor-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

Monitoring of serum squamous cell carcinoma antigen levels in invasive cervical cancer: is it cost-effective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

Detection of squamous-cell carcinoma antigen-expressing tumour cells in blood by reverse transcriptase-polymerase chain reaction in cancer of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

Cancer of the uterine cervix: sensitivity and specificity of serum squamous cell carcinoma antigen determinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

Tumor antigen of human cervical squamous cell carcinoma.Correlation of circulating levels with disease progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.104

21 January 2018

Identifiers

DOI

10.1515/CCLM.2006.104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16681421%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference